Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
SUM149PT | Torin2 | mTOR/ATM/ATR | PI3K/mTOR | 0.14108 | 0.0001 | 0.2579 | 0.0501 | 0.5792 | 0.76606 | 0.99281 |
SUM149PT | Everolimus | mTOR1 | PI3K/mTOR | Inf | 0.7389 | 0.2003 | 0.0098 | 0.2094 | 0.00021362 | 0.67353 |
SUM149PT | INK-128 | mTORC1/2 | PI3K/mTOR | 0.16131 | 0.2613 | 0.3199 | 0.0092 | 0.6928 | 0.056936 | 0.98747 |
SUM149PT | PF-4708671 | p70S6K | PI3K/mTOR | 20.5582 | 0.7287 | 0.0241 | 0.0090 | 1.0700 | 53.3219 | 0.95776 |
SUM149PT | Buparlisib | pan PI3K | PI3K/mTOR | 1.4121 | -0.3357 | 0.2539 | 0.1216 | 1.9093 | 1.9133 | 0.99941 |
SUM149PT | Pictilisib | pan PI3K | PI3K/mTOR | 5.8499 | 0.3333 | 0.1214 | 0.0038 | 0.7167 | 27.0916 | 0.9899 |
SUM149PT | Ceritinib | ALK | RTK | 1.6908 | -0.4396 | 0.2518 | 0.1219 | 2.1905 | 2.3199 | 0.99787 |
SUM149PT | Neratinib | EGFR/HER2 | RTK | 0.067993 | 0.1521 | 0.3623 | 0.0339 | 1.2974 | 0.048589 | 0.99455 |
SUM149PT | Tivantinib | MET | RTK | 0.27624 | -0.2313 | 0.4502 | 0.1850 | 2.3039 | 0.32281 | 0.99937 |
SUM149PT | Cediranib | VEGFR/cKIT | RTK | 5.5644 | 0.0656 | 0.0552 | 0.0262 | 2.8599 | 6.1559 | 0.99049 |
SUM149PT | Cabozantinib | VEGFR2/MET | RTK | 5.7589 | 0.2895 | 0.0383 | 0.0198 | 4.7896 | 4.9143 | 0.99303 |
T47D | Abemaciclib | CDK4/6 | Cell cycle | 0.0042816 | -0.0412 | 0.7664 | 0.0265 | 1.3858 | 0.0037683 | 0.95899 |
T47D | Palbociclib | CDK4/6 | Cell cycle | 0.027507 | 0.1166 | 0.4501 | 0.0077 | 1.5536 | 0.022367 | 0.99262 |
T47D | AZD7762 | CHK1/2 | Cell cycle | 2.3432 | -0.0573 | 0.1322 | 0.0195 | 2.6709 | 2.4809 | 0.98871 |
T47D | Volasertib | PLK | Cell cycle | 0.031411 | -0.1585 | 0.3959 | 0.0580 | 1.7544 | 0.036365 | 0.99393 |
T47D | Dinaciclib | pan CDK | Cell cycle | 0.019853 | -0.2109 | 0.4815 | 0.0484 | 5.0000 | 0.021113 | 0.99494 |
T47D | Cisplatin | Chemo | Chemotherapy | 1.5698 | 0.1019 | 0.2147 | 0.0055 | 1.3290 | 1.5705 | 0.98121 |
T47D | Doxorubicin | Chemo | Chemotherapy | 0.0018887 | -0.3611 | 0.9189 | 0.1014 | 1.2268 | 0.0024801 | 0.96538 |
T47D | Taxol | Chemo | Chemotherapy | 0.0035285 | -0.1337 | 0.6636 | 0.2505 | 2.2353 | 0.0038792 | 0.99665 |
T47D | Topotecan | Topo I | Chemotherapy | 0.0052275 | -0.1971 | 0.9594 | 0.1261 | 1.3094 | 0.0068541 | 0.99083 |
T47D | Etoposide | Topo II | Chemotherapy | 0.041662 | -0.1861 | 0.6661 | 0.0533 | 1.1976 | 0.051932 | 0.98563 |
T47D | Dasatinib | BCR/ABL | MAPK/nRTK | 12.5697 | 0.4961 | 0.1933 | 0.0086 | 0.2753 | 679.7315 | 0.95229 |
T47D | Trametinib | MEK | MAPK/nRTK | Inf | 0.5801 | 0.2130 | 0.0041 | 0.9941 | 0.0048584 | 0.90394 |
T47D | Saracatinib | SRC | MAPK/nRTK | 3.9647 | 0.3892 | 0.1722 | 0.0087 | 0.6928 | 1.6318 | 0.9752 |
T47D | ABT-737 | Bcl2/XL | Misc | 12.2023 | 0.5888 | 0.0010 | 0.0084 | 2.2890 | 9.7541 | 0.92156 |